Department of Microbiology and Immunology, University of Kentucky, College of Medicine, Lexington
Correspondence: Dr. Donald Cohen, Department of Microbiology and Immunology, University of Kentucky, College of Medicine, 800 Rose St., Lexington, KY 40536-0084. E-mail: dcohen{at}pop.uky.edu
The immunosuppressive activity of interleukin-10 (IL-10) makes this
cytokine a potentially important clinical tool to reduce inflammatory
responses in various diseases. Its efficacy as a therapeutic modality
is dependent on the responsiveness of immune cells. We report that
macrophages from mice chronically infected with the LP-BM5 retrovirus
had a reduced capacity to respond to IL-10 in vitro. The ability of
IL-10 to inhibit lipopolysaccharide-induced production of tumor
necrosis factor (TNF)
and IL-6 was significantly reduced in both
alveolar and peritoneal macrophages from infected versus uninfected
mice. IL-10 hyporesponsiveness was not related to direct infection by
the retrovirus, because bone marrow-derived macrophages infected in
vitro with LP-BM5 were as responsive to IL-10 as were uninfected bone
marrow-derived macrophages. TNF-
appeared to contribute to
development of IL-10 hyporesponsiveness, because exposure of normal
macrophages to TNF-
but not interferon-
reduced macrophage
responsiveness to IL-10. Reverse transcriptase-PCR and flow cytometry
demonstrated normal expression of the
and ß chains of the IL-10
receptor in macrophages from infected mice, suggesting that IL-10
hyporesponsiveness is not related to a change in receptor expression.
The potential role of reduced IL-10 responsiveness in the chronicity of
inflammation in this and other diseases is discussed.
Key Words: cytokine inflammation retroviruses TNF-
This article has been cited by other articles:
![]() |
K Nakagome, M Dohi, K Okunishi, R Tanaka, J Miyazaki, and K Yamamoto In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-{beta} in the lung Thorax, October 1, 2006; 61(10): 886 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Herrero, X. Hu, W. P. Li, S. Samuels, M. N. Sharif, S. Kotenko, and L. B. Ivashkiv Reprogramming of IL-10 Activity and Signaling by IFN-{gamma} J. Immunol., November 15, 2003; 171(10): 5034 - 5041. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-D. Ji, I. Tassiulas, K.-H. Park-Min, A. Aydin, I. Mecklenbrauker, A. Tarakhovsky, L. Pricop, J. E. Salmon, and L. B. Ivashkiv Inhibition of Interleukin 10 Signaling after Fc Receptor Ligation and during Rheumatoid Arthritis J. Exp. Med., June 2, 2003; 197(11): 1573 - 1583. [Abstract] [Full Text] [PDF] |
||||